nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Erythema facial—Hydroxyurea—brain cancer	0.054	0.0676	CcSEcCtD
Fludrocortisone—Papilloedema—Procarbazine—brain cancer	0.0401	0.0502	CcSEcCtD
Fludrocortisone—Osteonecrosis—Procarbazine—brain cancer	0.0342	0.0428	CcSEcCtD
Fludrocortisone—Atrophy—Hydroxyurea—brain cancer	0.0303	0.0379	CcSEcCtD
Fludrocortisone—Contusion—Lomustine—brain cancer	0.023	0.0288	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Procarbazine—brain cancer	0.0214	0.0268	CcSEcCtD
Fludrocortisone—Optic neuritis—Procarbazine—brain cancer	0.0207	0.0259	CcSEcCtD
Fludrocortisone—Intracranial pressure increased—Carmustine—brain cancer	0.0191	0.0239	CcSEcCtD
Fludrocortisone—Impaired healing—Carmustine—brain cancer	0.0184	0.0231	CcSEcCtD
Fludrocortisone—Neoplasm—Lomustine—brain cancer	0.0181	0.0227	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Hydroxyurea—brain cancer	0.0166	0.0208	CcSEcCtD
Fludrocortisone—NR3C2—hindbrain—brain cancer	0.0164	0.0989	CbGeAlD
Fludrocortisone—Petechiae—Procarbazine—brain cancer	0.0155	0.0194	CcSEcCtD
Fludrocortisone—Amenorrhoea—Procarbazine—brain cancer	0.0145	0.0182	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Carmustine—brain cancer	0.0134	0.0168	CcSEcCtD
Fludrocortisone—Amenorrhoea—Hydroxyurea—brain cancer	0.0112	0.014	CcSEcCtD
Fludrocortisone—Myopathy—Temozolomide—brain cancer	0.011	0.0138	CcSEcCtD
Fludrocortisone—Vascular purpura—Procarbazine—brain cancer	0.0103	0.0129	CcSEcCtD
Fludrocortisone—Haemoglobin—Lomustine—brain cancer	0.0101	0.0127	CcSEcCtD
Fludrocortisone—Haemorrhage—Lomustine—brain cancer	0.0101	0.0126	CcSEcCtD
Fludrocortisone—Optic neuritis—Etoposide—brain cancer	0.01	0.0125	CcSEcCtD
Fludrocortisone—Purpura—Procarbazine—brain cancer	0.0096	0.012	CcSEcCtD
Fludrocortisone—NR3C2—brainstem—brain cancer	0.00939	0.0567	CbGeAlD
Fludrocortisone—Petechiae—Temozolomide—brain cancer	0.00936	0.0117	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Hydroxyurea—brain cancer	0.00896	0.0112	CcSEcCtD
Fludrocortisone—Neoplasm—Hydroxyurea—brain cancer	0.00892	0.0112	CcSEcCtD
Fludrocortisone—NR3C1—hindbrain—brain cancer	0.00878	0.053	CbGeAlD
Fludrocortisone—Amenorrhoea—Temozolomide—brain cancer	0.00877	0.011	CcSEcCtD
Fludrocortisone—NR3C2—telencephalon—brain cancer	0.00833	0.0503	CbGeAlD
Fludrocortisone—Infection—Carboplatin—brain cancer	0.00813	0.0102	CcSEcCtD
Fludrocortisone—Pancreatitis—Procarbazine—brain cancer	0.00784	0.00981	CcSEcCtD
Fludrocortisone—Sweating increased—Procarbazine—brain cancer	0.00779	0.00975	CcSEcCtD
Fludrocortisone—Neoplasm—Carmustine—brain cancer	0.00721	0.00902	CcSEcCtD
Fludrocortisone—Infection—Lomustine—brain cancer	0.00711	0.0089	CcSEcCtD
Fludrocortisone—Neoplasm—Temozolomide—brain cancer	0.00697	0.00872	CcSEcCtD
Fludrocortisone—NR3C2—pituitary gland—brain cancer	0.00678	0.0409	CbGeAlD
Fludrocortisone—Thrombophlebitis—Carmustine—brain cancer	0.00668	0.00837	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Carmustine—brain cancer	0.00665	0.00833	CcSEcCtD
Fludrocortisone—NR3C2—medulla oblongata—brain cancer	0.00654	0.0395	CbGeAlD
Fludrocortisone—Thrombophlebitis—Temozolomide—brain cancer	0.00646	0.00809	CcSEcCtD
Fludrocortisone—Haemoglobin—Procarbazine—brain cancer	0.00643	0.00805	CcSEcCtD
Fludrocortisone—Haemorrhage—Procarbazine—brain cancer	0.0064	0.00801	CcSEcCtD
Fludrocortisone—Injury—Carmustine—brain cancer	0.0063	0.00788	CcSEcCtD
Fludrocortisone—Vascular purpura—Temozolomide—brain cancer	0.00625	0.00783	CcSEcCtD
Fludrocortisone—AR—telencephalon—brain cancer	0.00617	0.0372	CbGeAlD
Fludrocortisone—Pancreatitis—Hydroxyurea—brain cancer	0.00607	0.00759	CcSEcCtD
Fludrocortisone—NR3C2—midbrain—brain cancer	0.00598	0.0361	CbGeAlD
Fludrocortisone—NR3C2—spinal cord—brain cancer	0.00584	0.0352	CbGeAlD
Fludrocortisone—Purpura—Temozolomide—brain cancer	0.0058	0.00726	CcSEcCtD
Fludrocortisone—Oesophagitis—Etoposide—brain cancer	0.00563	0.00705	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Etoposide—brain cancer	0.0056	0.00701	CcSEcCtD
Fludrocortisone—Affect lability—Temozolomide—brain cancer	0.0055	0.00689	CcSEcCtD
Fludrocortisone—Mood swings—Temozolomide—brain cancer	0.0053	0.00663	CcSEcCtD
Fludrocortisone—NR3C2—endocrine gland—brain cancer	0.00525	0.0317	CbGeAlD
Fludrocortisone—NR3C2—head—brain cancer	0.00519	0.0313	CbGeAlD
Fludrocortisone—AR—gonad—brain cancer	0.00515	0.0311	CbGeAlD
Fludrocortisone—Muscular weakness—Carmustine—brain cancer	0.0051	0.00639	CcSEcCtD
Fludrocortisone—NR3C1—brainstem—brain cancer	0.00503	0.0304	CbGeAlD
Fludrocortisone—AR—pituitary gland—brain cancer	0.00502	0.0303	CbGeAlD
Fludrocortisone—Haemoglobin—Hydroxyurea—brain cancer	0.00498	0.00623	CcSEcCtD
Fludrocortisone—Haemorrhage—Hydroxyurea—brain cancer	0.00495	0.0062	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Etoposide—brain cancer	0.00493	0.00618	CcSEcCtD
Fludrocortisone—Muscular weakness—Temozolomide—brain cancer	0.00493	0.00617	CcSEcCtD
Fludrocortisone—Abdominal distension—Temozolomide—brain cancer	0.00487	0.00609	CcSEcCtD
Fludrocortisone—Convulsion—Procarbazine—brain cancer	0.00483	0.00604	CcSEcCtD
Fludrocortisone—Hypertension—Procarbazine—brain cancer	0.00481	0.00602	CcSEcCtD
Fludrocortisone—Myalgia—Procarbazine—brain cancer	0.00474	0.00594	CcSEcCtD
Fludrocortisone—NR3C2—central nervous system—brain cancer	0.00473	0.0286	CbGeAlD
Fludrocortisone—Sweating increased—Temozolomide—brain cancer	0.00471	0.00589	CcSEcCtD
Fludrocortisone—NR3C2—cerebellum—brain cancer	0.00463	0.0279	CbGeAlD
Fludrocortisone—Anaphylactoid reaction—Etoposide—brain cancer	0.00462	0.00579	CcSEcCtD
Fludrocortisone—Oedema—Procarbazine—brain cancer	0.00455	0.00569	CcSEcCtD
Fludrocortisone—Infection—Procarbazine—brain cancer	0.00452	0.00565	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Carmustine—brain cancer	0.00451	0.00565	CcSEcCtD
Fludrocortisone—NR3C1—telencephalon—brain cancer	0.00447	0.027	CbGeAlD
Fludrocortisone—Hyperhidrosis—Procarbazine—brain cancer	0.00439	0.0055	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Temozolomide—brain cancer	0.00436	0.00546	CcSEcCtD
Fludrocortisone—AR—spinal cord—brain cancer	0.00432	0.0261	CbGeAlD
Fludrocortisone—Erythema—Hydroxyurea—brain cancer	0.00431	0.0054	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00414	0.00518	CcSEcCtD
Fludrocortisone—Insomnia—Procarbazine—brain cancer	0.00411	0.00515	CcSEcCtD
Fludrocortisone—Haemoglobin—Carmustine—brain cancer	0.00402	0.00504	CcSEcCtD
Fludrocortisone—Haemorrhage—Carmustine—brain cancer	0.004	0.00501	CcSEcCtD
Fludrocortisone—AR—endocrine gland—brain cancer	0.00389	0.0235	CbGeAlD
Fludrocortisone—Haemoglobin—Temozolomide—brain cancer	0.00389	0.00487	CcSEcCtD
Fludrocortisone—Haemorrhage—Temozolomide—brain cancer	0.00387	0.00484	CcSEcCtD
Fludrocortisone—AR—head—brain cancer	0.00384	0.0232	CbGeAlD
Fludrocortisone—Sweating increased—Etoposide—brain cancer	0.00377	0.00472	CcSEcCtD
Fludrocortisone—NR3C2—brain—brain cancer	0.00376	0.0227	CbGeAlD
Fludrocortisone—Convulsion—Hydroxyurea—brain cancer	0.00374	0.00468	CcSEcCtD
Fludrocortisone—NR3C1—gonad—brain cancer	0.00373	0.0225	CbGeAlD
Fludrocortisone—NR3C1—pituitary gland—brain cancer	0.00364	0.022	CbGeAlD
Fludrocortisone—Urticaria—Procarbazine—brain cancer	0.00361	0.00452	CcSEcCtD
Fludrocortisone—Oedema—Hydroxyurea—brain cancer	0.00352	0.0044	CcSEcCtD
Fludrocortisone—NR3C1—medulla oblongata—brain cancer	0.00351	0.0212	CbGeAlD
Fludrocortisone—AR—central nervous system—brain cancer	0.00351	0.0212	CbGeAlD
Fludrocortisone—Infection—Hydroxyurea—brain cancer	0.0035	0.00438	CcSEcCtD
Fludrocortisone—Erythema—Carmustine—brain cancer	0.00348	0.00436	CcSEcCtD
Fludrocortisone—Erythema—Temozolomide—brain cancer	0.00337	0.00422	CcSEcCtD
Fludrocortisone—Hypersensitivity—Procarbazine—brain cancer	0.00335	0.00419	CcSEcCtD
Fludrocortisone—Asthenia—Procarbazine—brain cancer	0.00326	0.00408	CcSEcCtD
Fludrocortisone—NR3C1—midbrain—brain cancer	0.00321	0.0194	CbGeAlD
Fludrocortisone—NR3C1—spinal cord—brain cancer	0.00313	0.0189	CbGeAlD
Fludrocortisone—Vertigo—Temozolomide—brain cancer	0.00303	0.00379	CcSEcCtD
Fludrocortisone—Convulsion—Carmustine—brain cancer	0.00302	0.00378	CcSEcCtD
Fludrocortisone—Hypertension—Carmustine—brain cancer	0.00301	0.00377	CcSEcCtD
Fludrocortisone—Myalgia—Carmustine—brain cancer	0.00297	0.00371	CcSEcCtD
Fludrocortisone—Convulsion—Temozolomide—brain cancer	0.00292	0.00365	CcSEcCtD
Fludrocortisone—Hypertension—Temozolomide—brain cancer	0.00291	0.00364	CcSEcCtD
Fludrocortisone—Myalgia—Temozolomide—brain cancer	0.00287	0.00359	CcSEcCtD
Fludrocortisone—Headache—Procarbazine—brain cancer	0.00285	0.00356	CcSEcCtD
Fludrocortisone—Oedema—Carmustine—brain cancer	0.00284	0.00356	CcSEcCtD
Fludrocortisone—Infection—Carmustine—brain cancer	0.00283	0.00354	CcSEcCtD
Fludrocortisone—NR3C1—endocrine gland—brain cancer	0.00282	0.017	CbGeAlD
Fludrocortisone—AR—brain—brain cancer	0.00278	0.0168	CbGeAlD
Fludrocortisone—NR3C1—head—brain cancer	0.00278	0.0168	CbGeAlD
Fludrocortisone—Oedema—Temozolomide—brain cancer	0.00275	0.00344	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Temozolomide—brain cancer	0.00275	0.00344	CcSEcCtD
Fludrocortisone—Infection—Temozolomide—brain cancer	0.00273	0.00342	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Temozolomide—brain cancer	0.00266	0.00333	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—KDM4C—brain cancer	0.00262	0.09	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Hydroxyurea—brain cancer	0.00259	0.00324	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Carmustine—brain cancer	0.00259	0.00324	CcSEcCtD
Fludrocortisone—Insomnia—Carmustine—brain cancer	0.00257	0.00322	CcSEcCtD
Fludrocortisone—NR3C1—central nervous system—brain cancer	0.00254	0.0153	CbGeAlD
Fludrocortisone—Asthenia—Hydroxyurea—brain cancer	0.00252	0.00316	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.0025	0.00313	CcSEcCtD
Fludrocortisone—Insomnia—Temozolomide—brain cancer	0.00249	0.00311	CcSEcCtD
Fludrocortisone—NR3C1—cerebellum—brain cancer	0.00248	0.015	CbGeAlD
Fludrocortisone—Vertigo—Etoposide—brain cancer	0.00242	0.00303	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—CYP2C9—brain cancer	0.00242	0.377	CrCbGaD
Fludrocortisone—Convulsion—Etoposide—brain cancer	0.00233	0.00292	CcSEcCtD
Fludrocortisone—Hypertension—Etoposide—brain cancer	0.00233	0.00291	CcSEcCtD
Fludrocortisone—Headache—Hydroxyurea—brain cancer	0.0022	0.00276	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Etoposide—brain cancer	0.0022	0.00275	CcSEcCtD
Fludrocortisone—Infection—Etoposide—brain cancer	0.00218	0.00274	CcSEcCtD
Fludrocortisone—Urticaria—Temozolomide—brain cancer	0.00218	0.00273	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Etoposide—brain cancer	0.00213	0.00266	CcSEcCtD
Fludrocortisone—Hypersensitivity—Carmustine—brain cancer	0.0021	0.00262	CcSEcCtD
Fludrocortisone—Asthenia—Carmustine—brain cancer	0.00204	0.00255	CcSEcCtD
Fludrocortisone—Hypersensitivity—Temozolomide—brain cancer	0.00202	0.00253	CcSEcCtD
Fludrocortisone—NR3C1—brain—brain cancer	0.00202	0.0122	CbGeAlD
Fludrocortisone—Asthenia—Temozolomide—brain cancer	0.00197	0.00247	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—OTX2—brain cancer	0.00182	0.0626	CbGpPWpGaD
Fludrocortisone—Headache—Carmustine—brain cancer	0.00178	0.00223	CcSEcCtD
Fludrocortisone—Urticaria—Etoposide—brain cancer	0.00175	0.00219	CcSEcCtD
Fludrocortisone—Headache—Temozolomide—brain cancer	0.00172	0.00216	CcSEcCtD
Fludrocortisone—Hypersensitivity—Etoposide—brain cancer	0.00162	0.00203	CcSEcCtD
Fludrocortisone—Asthenia—Etoposide—brain cancer	0.00158	0.00198	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00154	0.053	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP2C9—brain cancer	0.0014	0.218	CrCbGaD
Fludrocortisone—Headache—Etoposide—brain cancer	0.00138	0.00172	CcSEcCtD
Fludrocortisone—Testosterone—CYP2C9—brain cancer	0.00132	0.206	CrCbGaD
Fludrocortisone—Dexamethasone—CYP2C9—brain cancer	0.00128	0.199	CrCbGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.00115	0.0394	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—SHH—brain cancer	0.00101	0.0346	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—ESR2—brain cancer	0.000906	0.0311	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000716	0.0246	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.000691	0.0237	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.000688	0.0236	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.000687	0.0236	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.000655	0.0225	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.000593	0.0204	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000559	0.0192	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000543	0.0187	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000522	0.0179	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000424	0.0146	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000369	0.0127	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000365	0.0125	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000311	0.0107	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000301	0.0103	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000295	0.0101	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000293	0.0101	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.000289	0.00992	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000286	0.00984	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR2—brain cancer	0.000266	0.00916	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000259	0.00891	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH2—brain cancer	0.000252	0.00867	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000249	0.00855	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000247	0.0085	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000247	0.00848	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.000244	0.00838	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000242	0.00831	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.000242	0.0083	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000232	0.00799	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000228	0.00785	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.000227	0.00781	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000222	0.00763	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000205	0.00706	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000204	0.00702	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.0002	0.00689	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000198	0.0068	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000196	0.00675	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000196	0.00674	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000194	0.00668	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000184	0.00632	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000183	0.00629	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.00018	0.0062	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000179	0.00614	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000175	0.00603	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000172	0.00592	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.00017	0.00584	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000168	0.00577	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IRS2—brain cancer	0.000167	0.00573	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000166	0.00572	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000166	0.0057	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000164	0.00564	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000158	0.00541	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000156	0.00536	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.000156	0.00535	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000152	0.00521	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.00015	0.00515	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—DNMT1—brain cancer	0.000143	0.00491	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000143	0.0049	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000141	0.00486	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.000133	0.00457	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR2—brain cancer	0.000128	0.00441	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR2—brain cancer	0.000124	0.00425	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH2—brain cancer	0.000122	0.00418	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000118	0.00407	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000118	0.00406	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000117	0.00402	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000117	0.00402	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000114	0.00392	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000111	0.00381	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—brain cancer	0.000109	0.00375	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SIRT1—brain cancer	0.000103	0.00355	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000103	0.00354	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.0001	0.00345	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CTNNB1—brain cancer	0.0001	0.00344	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.79e-05	0.00336	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.69e-05	0.00333	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	9.62e-05	0.00331	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	9.48e-05	0.00326	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	9.38e-05	0.00322	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	9.27e-05	0.00318	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	8.89e-05	0.00305	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—brain cancer	8.72e-05	0.003	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	8.65e-05	0.00297	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.53e-05	0.00293	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—brain cancer	8.41e-05	0.00289	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.85e-05	0.0027	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	7.78e-05	0.00267	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.68e-05	0.00264	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	7.61e-05	0.00262	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—DNMT1—brain cancer	6.63e-05	0.00228	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.45e-05	0.00222	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR2—brain cancer	5.95e-05	0.00205	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH2—brain cancer	5.64e-05	0.00194	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—DNMT1—brain cancer	5.03e-05	0.00173	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SIRT1—brain cancer	4.79e-05	0.00165	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR2—brain cancer	4.52e-05	0.00155	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH2—brain cancer	4.28e-05	0.00147	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—brain cancer	4.05e-05	0.00139	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—brain cancer	3.9e-05	0.00134	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SIRT1—brain cancer	3.64e-05	0.00125	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—brain cancer	2.96e-05	0.00102	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—brain cancer	1.88e-05	0.000645	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—brain cancer	1.42e-05	0.00049	CbGpPWpGaD
